NDMAC opposes recommended label comprehension trials to support switches in Canada.
This article was originally published in The Tan Sheet
Executive Summary
OTC SWITCH MANDATORY LABEL COMPREHENSION STUDIES "PREMATURE" IN CANADA, the Nonprescription Drug Manufacturers Association of Canada said in June 28 comments submitted to the Drugs Directorate. The comments respond to specific points made in a final report on the Rx-to-OTC switch process in Canada, prepared for the Bureau of Pharmaceutical Assessment by Panacea Consulting ("The Tan Sheet" May 27, p. 13).